Ava C Kelley

1PUBLICATIONS
4CO-AUTHORS
Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 09, 2020
Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children's Oncology Group.

Brandon J Diessner, Nathan Pankratz, Anthony J Hooten

Pageof 1

Frequent Collaborators

1 joint publications

Brandon J Diessner

1 joint publications

Nathan Pankratz

1 joint publications

Lauren J Mills

1 joint publications

Logan G Spector